4.4 Article

RAGE Against the Glycation Machine in Synucleinopathies: Time to Explore New Questions

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies

Jacob S. Deyell et al.

Summary: Synucleinopathies are devastating neurodegenerative diseases characterized by abnormal accumulation of the protein alpha-synuclein. Microglia, the immune cells in the central nervous system, play a crucial role in the pathogenesis of synucleinopathies. They are initially neuroprotective but contribute to further neurodegeneration in chronic disease states. This review highlights the structural varieties of alpha-synuclein, microglial receptor-mediated interactions, cellular recognition and uptake of alpha-synuclein, and downstream effects leading to neuroinflammation and neurodegeneration. Understanding microglial interactions with alpha-synuclein is vital for identifying therapeutic interventions and gauging potential pathways of neurodegeneration.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Post-translational modification of lysine residues in erythrocyte α-synuclein

Ryosuke Amagai et al.

Summary: alpha-Synuclein is a protein associated with various synuclein-associated diseases, and is highly expressed in the central nervous system and in erythrocytes. This study analyzed the post-translational modifications of erythrocyte alpha-synuclein and found that all lysine residues in the protein could be modified by different methods, but phosphorylation, nitration, and acylation were rare in erythrocytes. These findings provide new insight into the progression of synucleinopathies and suggest potential therapeutic strategies targeting alpha-synuclein.

JOURNAL OF BIOCHEMISTRY (2023)

Review Immunology

A functional role for alpha-synuclein in neuroimmune responses

Dustin L. Heiden et al.

Summary: This review discusses the role of alpha-synuclein in the pathogenesis of Parkinson's disease and other synucleinopathies, specifically its involvement in immune responses within the nervous system. Recent studies show that alpha-synuclein supports interferon signaling in neurons and is released to activate glial cells and infiltrating immune cells. Inflammatory activation and interferon signaling also lead to post-translational modifications of alpha-synuclein associated with Parkinson's disease. Understanding the complex interactions between alpha-synuclein and immune responses may offer potential therapeutic targets for Parkinson's disease.

JOURNAL OF NEUROIMMUNOLOGY (2023)

Article Behavioral Sciences

Targeting α-synuclein post-translational modifications in Parkinson's disease

Jaquelini B. Canever et al.

Summary: This review provides an overview of the pathophysiological roles of alpha-synuclein in Parkinson's disease and discusses various post-translational modifications that are implicated in its functions. It also highlights the potential of alpha-synuclein PTMs as biomarkers for PD.

BEHAVIOURAL BRAIN RESEARCH (2023)

Article Neurosciences

An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels

Iris N. Serratos et al.

Summary: The aggregation of alpha-synuclein plays a critical role in the development of Parkinson's disease and other synucleinopathies. Changes in protein conformation due to mutations and post-translational modifications lead to the abnormal aggregation of alpha-synuclein, which contributes to the progression of these diseases.

MOLECULAR NEUROBIOLOGY (2022)

Article Cell Biology

Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function

Md Masud Alam et al.

Summary: Recent studies have shown that alpha-synuclein plays a crucial role in normal vertebrate physiology and is a critical mediator of inflammatory and immune responses. Neural cells are the sources of alpha-synuclein required for immune competence.

CELL REPORTS (2022)

Article Biochemistry & Molecular Biology

Role of glyoxalase 1 in methylglyoxal detoxification-the broad player of psychiatric disorders

Kazuya Toriumi et al.

Summary: Methylglyoxal (MG) is a reactive alpha-ketoaldehyde produced as a byproduct of the glycolytic pathway. Recent research has shown that the expression of glyoxalase 1 (GLO1) and the accumulation of MG in the brain are related to the pathogenesis of psychiatric disorders. Therefore, GLO1 may be a potential target for the treatment of these disorders.

REDOX BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Glycation modulates alpha-synuclein fibrillization kinetics: A sweet spot for inhibition

Azad Farzadfard et al.

Summary: This study reveals the inhibitory effect of glycation on alpha-synuclein fibril formation and provides insights into its molecular mechanism. Glycation primarily affects the elongation of alpha-synuclein and has a modest impact on oligomerization.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Neurosciences

Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease

Alysa Kasen et al.

Summary: Alpha-synuclein plays multiple roles in neurons and is involved in the pathogenesis of synucleinopathies. Recent evidence suggests its potential involvement in the immune response, and under certain conditions, its aggregation may trigger neurodegenerative diseases.

NEUROBIOLOGY OF DISEASE (2022)

Article Neurosciences

Glycation modulates glutamatergic signaling and exacerbates Parkinson's disease-like phenotypes

Ana Chegao et al.

Summary: This study found that MGO-induced glycation accelerates PD-like sensorimotor and cognitive alterations and increases the accumulation of α-synuclein in the brain. In addition, the study also found that MGO mainly affects glutamatergic signaling in the midbrain, which may be associated with PD and dopaminergic pathways.

NPJ PARKINSONS DISEASE (2022)

Review Respiratory System

Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation

Kakuhiro Yamaguchi et al.

Summary: RAGE receptor plays a homeostatic role in the lung, but its abnormal binding may lead to lung injury and the occurrence of ILD, including IPF. IPF patients have a poor prognosis, with AE-IPF being one of the main causes of death. ILD is frequently observed in patients with lung cancer, and procedures or chemotherapy may trigger AE-ILD, leading to increased mortality.

RESPIRATORY INVESTIGATION (2022)

Review Biochemistry & Molecular Biology

Synucleins: New Data on Misfolding, Aggregation and Role in Diseases

Andrei Surguchov et al.

Summary: This article analyzes the main trends and developments in synuclein research and discusses possible future directions. Comparative studies of structural features and functional research on the synuclein family members remain a focus of research. Another popular area of study is the mechanism of oc-synuclein accumulation, aggregation, and fibrillation. A recent and exciting area of research is alpha-synuclein and epigenetics.

BIOMEDICINES (2022)

Review Chemistry, Medicinal

Methylglyoxal and Its Adducts: Induction, Repair, and Association with Disease

Seigmund Wai Tsuen Lai et al.

Summary: MG and MG-AGEs, produced during metabolism, are associated with the onset and progression of various pathologies. Regulating MG and MG-AGEs may be a potential strategy for preventing diseases and using them as biomarkers for predicting disease risk and early intervention. This review provides an overview of recent advances and knowledge surrounding MG and discusses its clinical applications and therapeutic strategies to improve patient outcomes.

CHEMICAL RESEARCH IN TOXICOLOGY (2022)

Review Clinical Neurology

Diffusion Magnetic Resonance Imaging Microstructural Abnormalities in Multiple System Atrophy: A Comprehensive Review

Jacopo Pasquini et al.

Summary: This review summarizes the literature on the application of diffusion magnetic resonance imaging (dMRI) in multiple system atrophy (MSA), focusing on microstructural abnormalities, diagnostic applications, and pathophysiological correlates. The studies included in this review identified widespread microstructural abnormalities in white matter, especially in specific brain regions. Gray matter degeneration and its involvement in subcortical structures were also observed. Diagnostic applications of dMRI, particularly for differentiating MSA parkinsonism from Parkinson's disease, showed promising results with high diagnostic accuracy using machine learning algorithms. Additionally, some studies explored the clinical correlates of microstructural abnormalities, highlighting links with motor, ocular, and cognitive impairments. However, the correct diagnosis of MSA in the early stages and further investigation of the pathophysiological mechanisms underlying microstructural abnormalities are still challenging.

MOVEMENT DISORDERS (2022)

Article Cell Biology

Interaction of RAGE with a-synuclein fibrils mediates inflammatory response of microglia

Houfang Long et al.

Summary: This study reveals that RAGE serves as a receptor of α-syn fibrils on microglia, and its binding with α-syn induces neuroinflammation. The structural mechanism of RAGE in mediating the inflammatory response to α-syn fibrils is validated.

CELL REPORTS (2022)

Review Microbiology

Advanced Glycation End Products in Health and Disease

V. Prakash Reddy et al.

Summary: Advanced glycation end products (AGEs), formed through nonenzymatic reactions, play a significant role in the pathogenesis of various diseases, including diabetes, atherosclerosis, and Alzheimer's disease. The interactions of AGEs with their receptors (RAGE) and Maillard reactions in gut microbiota also contribute to disease progression.

MICROORGANISMS (2022)

Review Biochemistry & Molecular Biology

Interactions of α-synuclein oligomers with lipid membranes

Greta Musteikyte et al.

Summary: Parkinson's disease is an incurable neurodegenerative disorder characterized by the formation of Lewy bodies. Oligomeric forms of the protein alpha-synuclein interacting with lipid membranes are considered the main pathogenic species. Understanding the structural and biophysical features of these oligomers and their interactions with membranes is crucial for deciphering the etiology of Parkinson's disease and its toxicity in vivo.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2021)

Review Biochemistry & Molecular Biology

Expatiating the molecular approaches of HMGB1 in diabetes mellitus: Highlighting signalling pathways via RAGE and TLRs

Tapan Behl et al.

Summary: Diabetes mellitus is a major healthcare challenge globally, with inflammation being a key pathogenic mechanism affecting various body parts. High-mobility group box 1 (HMGB1) is a significant non-histone protein triggering the inflammatory response, making it a potential target in diabetes research.

MOLECULAR BIOLOGY REPORTS (2021)

Article Clinical Neurology

Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease

Sara Konstantin Nissen et al.

Summary: This study found that sCD163 in the CSF of PD patients correlated with PD biomarkers and cognition scores, supporting monocyte involvement in neurodegeneration and cognition in PD. An increase in CSF-sCD163 in female patients suggested a sex-distinctive monocyte response. In vitro studies showed the potential connection between CD163 and alpha-synuclein, indicating a role for monocytes in both peripheral and brain immune responses to PD.

MOVEMENT DISORDERS (2021)

Review Neurosciences

Neuropathology and molecular diagnosis of Synucleinopathies

Shunsuke Koga et al.

Summary: Synucleinopathies are a group of diseases characterized by pathological aggregates of alpha-synuclein in neurons and glia. The two main disease entities are Lewy body disease and multiple system atrophy, each with different clinical subtypes. Currently, there are no disease-modifying therapies, but research on molecular mechanisms provides hope for future treatments.

MOLECULAR NEURODEGENERATION (2021)

Article Multidisciplinary Sciences

Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia

Dorit Trudler et al.

Summary: Parkinson's disease is associated with the accumulation of alpha-synuclein and activation of microglia, potentially leading to neuronal death. This study shows that alpha-synuclein can activate NLRP3 inflammasome in human microglia and that alpha-synuclein-antibody complexes can exacerbate inflammation in a human context.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Clinical Neurology

The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy

Tim E. Moors et al.

Summary: Research has shown that various post-translationally modified proteoforms of alpha-synuclein accumulate in Lewy bodies in different regions of the Parkinson's disease brain, providing insights into the orchestration of Lewy pathology. High-resolution and 3D multicolor microscopy in post-mortem human brain tissues offer potential mechanisms underlying a regulated Lewy body morphogenesis.

ACTA NEUROPATHOLOGICA (2021)

Review Clinical Neurology

Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications

Rosie Bell et al.

Summary: This article discusses the features and pathophysiology of Parkinson's disease and related synucleinopathies, emphasizing the potential importance of the dysregulation of lipid homeostasis and alpha-synuclein homeostasis in disease development. It also explores the role of post-translational modifications in modulating the interactions of alpha-synuclein with lipid membranes, and the impact of these advancements on the development of new diagnostic and therapeutic tools.

FRONTIERS IN NEUROLOGY (2021)

Review Biochemistry & Molecular Biology

Cellular models of alpha-synuclein toxicity and aggregation

Marion Delenclos et al.

JOURNAL OF NEUROCHEMISTRY (2019)

Review Neurosciences

Gastrointestinal Immunity and Alpha-Synuclein

Denise Barbut et al.

JOURNAL OF PARKINSONS DISEASE (2019)

Letter Clinical Neurology

Enteric alpha-synuclein expression is increased in Crohn's disease

Alice Prigent et al.

ACTA NEUROPATHOLOGICA (2019)

Article Biochemistry & Molecular Biology

Disruptive membrane interactions of alpha-synuclein aggregates

Aditya Iyer et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)

Article Cell & Tissue Engineering

CRISPR/Cas9 Edited sRAGE-MSCs Protect Neuronal Death in Parkinson's Disease Model

Aesuk Lee et al.

INTERNATIONAL JOURNAL OF STEM CELLS (2019)

Article Neurosciences

AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression

Hyun Jin Cho et al.

TRANSLATIONAL NEURODEGENERATION (2018)

Article Immunology

A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity

Ethan Stolzenberg et al.

JOURNAL OF INNATE IMMUNITY (2017)

Article Medicine, General & Internal

Increased risk of Parkinson disease with diabetes mellitus in a population-based study

Yu-Wan Yang et al.

MEDICINE (2017)

Article Multidisciplinary Sciences

Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation

Juciano Gasparotto et al.

SCIENTIFIC REPORTS (2017)

Review Neurosciences

The Synucleinopathies: Twenty Years On

Michel Goedert et al.

JOURNAL OF PARKINSONS DISEASE (2017)

Review Cell Biology

Lysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin

Nicoletta Plotegher et al.

AGEING RESEARCH REVIEWS (2016)

Article Neurosciences

Presymptomatic MPTP Mice Show Neurotrophic S100B/mRAGE Striatal Levels

Sofia D. Viana et al.

CNS NEUROSCIENCE & THERAPEUTICS (2016)

Review Biochemistry & Molecular Biology

Pathways of the Maillard reaction under physiological conditions

Christian Henning et al.

GLYCOCONJUGATE JOURNAL (2016)

Review Neurosciences

Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease

Heather E. Allen Reish et al.

JOURNAL OF PARKINSONS DISEASE (2015)

Article Clinical Neurology

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

Douglas Galasko et al.

NEUROLOGY (2014)

Article Immunology

RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA

Cherilyn M. Sirois et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Review Cell Biology

RAGE regulation and signaling in inflammation and beyond

Katrin Kierdorf et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2013)

Article Geriatrics & Gerontology

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity

Peter Teismann et al.

NEUROBIOLOGY OF AGING (2012)

Article Clinical Neurology

PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease

Marwan N. Sabbagh et al.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2011)

Article Biochemistry & Molecular Biology

Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress

Alexander Kurz et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2011)

Article Biochemistry & Molecular Biology

S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling

Alejandro Villarreal et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Article Multidisciplinary Sciences

In vivo demonstration that α-synuclein oligomers are toxic

Beate Winner et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models

Damla Pinar Karpinar et al.

EMBO JOURNAL (2009)

Article Biochemistry & Molecular Biology

Identification, classification, and expression of RAGE gene splice variants

Barry I. Hudson et al.

FASEB JOURNAL (2008)

Article Clinical Neurology

Evidence of oxidative stress in the neocortex in incidental Lewy body disease

E Dalfó et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)

Article Multidisciplinary Sciences

Double-knockout mice for α- and β-synucleins:: Effect on synaptic functions

S Chandra et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Urology & Nephrology

The AGE-RAGE system and diabetic nephropathy

S Sakurai et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)

Article Biochemistry & Molecular Biology

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

R Deane et al.

NATURE MEDICINE (2003)

Article Biochemistry & Molecular Biology

Crosslinking of α-synuclein by advanced glycation endproducts -: an early pathophysiological step in Lewy body formation?

G Münch et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2000)